Literature DB >> 16518793

Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity.

Anirban Basu1, Bhakti V Arondekar, Paul J Rathouz.   

Abstract

We investigate how the scale of estimation in risk-adjustment models for health-care costs affects the covariate effect, where the scale of interest for the covariate effect may be different from the scale of estimation. As an illustrative example, we use claims data to estimate the incremental costs associated with heart failure within one year subsequent to myocardial infarction. Here, the scale of interest for the effect of heart failure on costs is additive. However, traditional methods for modeling costs use predetermined scale of estimation - for example, ordinary least squares (OLS) regression assumes an additive scale while log-transformed OLS and generalized linear models with log-link assume a multiplicative scale of estimation. We compare these models with a new flexible model that lets the data determine the appropriate scale of estimation. We use a variety of goodness-of-fit measures along with a modified Copas test to assess robustness, lack of fit, and over-fitting properties of the alternative estimators. Biases up to 19% in the scale of interest are observed due to the misrepresentation of the scale of estimation. The new flexible model is found to appropriately represent the scale of estimation and less susceptible to over-fitting despite estimating additional parameters in the link and the variance functions. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16518793     DOI: 10.1002/hec.1099

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  24 in total

1.  Medical care costs associated with traumatic brain injury over the full spectrum of disease: a controlled population-based study.

Authors:  Cynthia L Leibson; Allen W Brown; Kirsten Hall Long; Jeanine E Ransom; Jay Mandrekar; Turner M Osler; James F Malec
Journal:  J Neurotrauma       Date:  2012-04-26       Impact factor: 5.269

2.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study.

Authors:  Kevin P Cohoon; Cynthia L Leibson; Jeanine E Ransom; Aneel A Ashrani; Myung S Park; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; John A Heit
Journal:  Surgery       Date:  2015-01-26       Impact factor: 3.982

4.  Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study.

Authors:  Kevin P Cohoon; Jeanine E Ransom; Cynthia L Leibson; Aneel A Ashrani; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; John A Heit
Journal:  Am J Med       Date:  2016-03-21       Impact factor: 4.965

5.  Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study.

Authors:  Cynthia L Leibson; Kirsten Hall Long; Jeanine E Ransom; Rosebud O Roberts; Steven L Hass; Amy M Duhig; Carin Y Smith; Jane A Emerson; V Shane Pankratz; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2015-04-06       Impact factor: 21.566

6.  Objective Estimates of Direct-Medical Costs Among Persons Aged 3 to 38 Years With and Without Research-Defined Autism Spectrum Disorder Ascertained During Childhood: A Population-Based Birth-Cohort Study.

Authors:  Cynthia Leibson; Amy Weaver; Scott Myers; Kirsten Long; Jeanine Ransom; Robert Voigt; Slavica Katusic
Journal:  Value Health       Date:  2020-02-27       Impact factor: 5.725

7.  Estimating incremental costs with skew: a cautionary note.

Authors:  Linnea A Polgreen; John M Brooks
Journal:  Appl Health Econ Health Policy       Date:  2012-09-01       Impact factor: 2.561

8.  Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTION.

Authors:  Shelby D Reed; Yanhong Li; Stephen J Ellis; John J Isitt; Sunfa Cheng; Kevin A Schulman; David J Whellan
Journal:  J Card Fail       Date:  2012-10       Impact factor: 5.712

Review 9.  Use of Claims Data for Cost and Cost-Effectiveness Research.

Authors:  Ya-Chen Tina Shih; Lei Liu
Journal:  Semin Radiat Oncol       Date:  2019-10       Impact factor: 5.934

10.  Costs of venous thromboembolism associated with hospitalization for medical illness.

Authors:  Kevin P Cohoon; Cynthia L Leibson; Jeanine E Ransom; Aneel A Ashrani; Tanya M Petterson; Kirsten Hall Long; Kent R Bailey; Johm A Heit
Journal:  Am J Manag Care       Date:  2015-04-01       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.